← Back to Search

VR Intervention for Caregiver Stress

N/A
Recruiting
Led By Lena Jumin Lee (Park), Ph.D.
Research Sponsored by National Institutes of Health Clinical Center (CC)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks

Summary

This trial tests if a nature-based immersive virtual reality helps reduce stress in caregivers of HSCT patients.

Who is the study for?
This trial is for adults over 18 who are the main caregivers for patients undergoing their first allogeneic HSCT at NIH Clinical Center. They must be able to understand English and have access to online survey tools. Only one primary caregiver per patient can join, and they should not be participating in other stress-reduction studies or have certain medical conditions.
What is being tested?
The study tests if a nature-based VR program can reduce stress in caregivers of HSCT patients. Participants use a VR headset daily for four weeks, providing saliva and blood samples while also completing weekly surveys about their stress levels.
What are the potential side effects?
There may be no direct side effects from the virtual reality experience itself; however, individuals prone to nausea, dizziness, seizures, or with balance disorders like vertigo might experience discomfort or adverse reactions when using the VR headset.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Changes in perceived stress
Secondary study objectives
Changes in symptoms (fatigue, sleep disturbance, depression, anxiety, cognitive impairment), acceptability (satisfaction, usability), acceptability (safety) (Cross) (Cross) (Cross)

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Active VR GroupExperimental Treatment1 Intervention
Nature-based immersive VR program, completion of questionnaires, and saliva and blood sample submission.
Group II: Sham VR GroupPlacebo Group1 Intervention
Nature-based non-immersive VR program, completion of questionnaires, and saliva and blood sample submission.

Find a Location

Who is running the clinical trial?

National Institutes of Health Clinical Center (CC)Lead Sponsor
389 Previous Clinical Trials
30,879,673 Total Patients Enrolled
1 Trials studying Tumors
49,946 Patients Enrolled for Tumors
Lena Jumin Lee (Park), Ph.D.Principal InvestigatorNational Institutes of Health Clinical Center (CC)
2 Previous Clinical Trials
192 Total Patients Enrolled

Media Library

Nature-Based Virtual Reality (VR) Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05909202 — N/A
Tumors Research Study Groups: Sham VR Group, Active VR Group
Tumors Clinical Trial 2023: Nature-Based Virtual Reality (VR) Intervention Highlights & Side Effects. Trial Name: NCT05909202 — N/A
Nature-Based Virtual Reality (VR) Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05909202 — N/A
~145 spots leftby Sep 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top